SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-20-003125
Filing Date
2020-03-24
Accepted
2020-03-24 17:17:43
Documents
9
Period of Report
2020-03-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cvm_8k.htm 8-K 40426
2 AMENDED AND RESTATED UNDERWRITING AGREEMENT cvm_ex11.htm EX-1.1 364735
3 OPINION OF HART & HART, LLC cvm_ex51.htm EX-5.1 7265
4 CONSENT OF HART & HART, LLC cvm_ex23.htm EX-23.1 5192
5 PRESS RELEASE DATED MARCH 23, 2020 cvm_ex991.htm EX-99.1 14335
6 PRESS RELEASE DATED MARCH 24, 2020 cvm_ex992.htm EX-99.2 15116
7 IMAGE cvm_ex51000.jpg GRAPHIC 7482
8 IMAGE cvm_ex991000.jpg GRAPHIC 7114
9 IMAGE cvm_ex992000.jpg GRAPHIC 7114
  Complete submission text file 0001654954-20-003125.txt   478651
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Filer) CIK: 0000725363 (see all company filings)

IRS No.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-11889 | Film No.: 20739233
SIC: 2836 Biological Products, (No Diagnostic Substances)